Brain disease treatment at RMCH shows promising signs
Early results for a potentially revolutionary brain disease therapy given under compassionate use to a two-year-old has shown promise
Read moreEarly results for a potentially revolutionary brain disease therapy given under compassionate use to a two-year-old has shown promise
Read moreOur first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
Read moreStaff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research
Read moreThe first child in the UK has participated in an international research trial taking place at Royal Manchester Children’s Hospital.
Read moreAs part of the NIHR Your Path in Research campaign, we are shining a spotlight on Emma Charnock, a Senior Paediatric Oncology Research Nurse at Royal Manchester Children’s Hospital.
Read moreCongratulations are in order for many of our Research and Innovation team members, with five wins for MFT at the 2019 NIHR Greater Manchester Clinical Research Awards last night.
Read moreA Royal Manchester Children’s Hospital consultant has been awarded nearly £400,000 to carry out research into ‘early vs late’ stoma closure in babies.
Read moreA child with a life-limiting condition, who was the first person in the world to receive a pioneering gene therapy, is ‘doing well’ almost 10 months on from treatment.
Read more